Patrick Andre
24Patents
10h-index
31Co-inventors
75Inventor score
Filing activity: Oct 7, 1997 → Nov 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6682475B2 | Tension indicator for cardiac support device and method therefore | Human Necessities | 98 | Expired |
| US8153590B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 27 | Active |
| US6149355A | Ball nose end mill and a cutting insert for the ball nose end mill | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6496561B1 | Devices, methods and systems for delivery of X-ray | Human Necessities | 24 | Expired |
| US7358091B2 | Device and methods for identifying and treating aspirin non-responsive patients | Physics | 20 | Expired |
| US8455441B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 17 | Active |
| US10604520B2 | N-acyl amino acid compounds and methods of use | Chemistry; Metallurgy | 16 | Active |
| US9062298B2 | Antidotes for factor XA inhibitors and methods of using the same | Human Necessities | 12 | Active |
| US9388401B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 12 | Active |
| US8889129B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 11 | Active |
| US7785891B2 | Device and methods for identifying and treating aspirin non-responsive patients | Physics | 9 | Active |
| US7387777B2 | Methods of treating hemophilia or von willebrand disease with p-selectin | Physics | 9 | Expired |
| US11673887B2 | N-acyl amino acid compounds and methods of use | Chemistry; Metallurgy | 3 | Active |
| US8455440B2 | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor | Human Necessities | 2 | Active |
| US6046666A | Thermal actuator | Physics | 2 | Expired |
| US6861504B2 | Compounds and methods for the modulation of CD154 | Human Necessities | 1 | Expired |
| US8946219B2 | Combination therapy with a compound acting as a platelet ADP receptor inhibitor | Human Necessities | 1 | Active |
| US8057815B2 | Methods of treatment with Syk inhibitors | Human Necessities | 1 | Active |
| US9023796B2 | Antidotes for factor XA inhibitors and methods of using the same | General | 0 | Revoked |
| US10675335B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 0 | Active |
| US7271152B2 | Compounds and methods for the modulation of CD154 | Human Necessities | 0 | Expired |
| US12134642B2 | Antibodies binding to α7β1 integrin antibodies and compositions thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8470357B2 | Methods of treatment with Syk inhibitors | Human Necessities | 0 | Active |
| US11839646B2 | Antidotes for factor Xa inhibitors and methods of using the same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.